The researchers from the Sydney Institute for Infectious Diseases at the University of Sydney, UNSW Sydney&rsq...
China-based Clover Biopharmaceuticals and Norway-based CEPI, the Coalition for Epidemic Preparedness Innovat...
China-based SINOVAC Biotech has announced that results from blind data analysis of a multi-centre, case-driven, ran...
mRNA Victoria, the agency of the Australian State of Victoria Government charged with building the State's mRNA man...
The government has approved a fund of 3,625 million baht for two Thai vaccine projects against COVID-19, ChulaCov19 mRNA...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and Q2 Solutions, a wholly owned subsidiary of ...
US-based Novavax, Inc. and Serum Institute of India have announced that the National Agency of Drug and Food Contro...
There is a common pearl of Indian wisdom that encourages parents to let their children play outside in the sun, rain, ga...
Taiwan's Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an indep...
Daiichi Sankyo has announced the progress of development of DS-5670, an mRNA vaccine in Japan, being evaluated against t...
There’s been a significant breakthrough in the development of a vaccine to prevent hookworm infection, a parasite ...
The Health Sciences Authority (HSA) in Singapore has granted an interim authorisation under the Pandemic Special Access ...
1. Who Is Eligible for a COVID Booster Shot? As of now, the U.S. Centers for Disease Control and Prevention (CD...
Taiwan-based Medigen Vaccine Biologics Corporation has recently stated that MVC-COV1901, a recombinant protein vacc...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Gamaleya National Research Cent...
Norway-based Coalition for Epidemic Preparedness Innovations, or CEPI, has launched a new call for proposals to fund cli...
American firm Moderna, Inc. will build a state-of-the-art mRNA facility in Africa with the goal of producing u...
The World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine (Mosquirix)...
